Author:
Shawish Ihab,Nafie Mohamed S.,Barakat Assem,Aldalbahi Ali,Al-Rasheed Hessa H.,Ali M.,Alshaer Walhan,Al Zoubi Mazhar,Al Ayoubi Samha,De la Torre Beatriz G.,Albericio Fernando,El-Faham Ayman
Abstract
A series of pyrazolyl-s-triazine compounds with an indole motif was designed, synthesized, and evaluated for anticancer activity targeting dual EGFR and CDK-2 inhibitors. The compounds were tested for cytotoxicity using the MTT assay. Compounds 3h, 3i, and 3j showed promising cytotoxic activity against two cancer cell lines, namely A549, MCF-7, and HDFs (non-cancerous human dermal fibroblasts). Compound 3j was the most active candidate against A549, with an IC50 of 2.32 ± 0.21 μM. Compounds 3h and 3i were found to be the most active hybrids against MCF-7 and HDFs, with an IC50 of 2.66 ± 0.26 μM and 3.78 ± 0.55 μM, respectively. Interestingly, 3i showed potent EGFR inhibition, with an IC50 of 34.1 nM compared to Erlotinib (IC50 = 67.3 nM). At 10 μM, this candidate caused 93.6% and 91.4% of EGFR and CDK-2 inhibition, respectively. Furthermore, 3i enhanced total lung cancer cell apoptosis 71.6-fold (43.7% compared to 0.61% for the control). Given the potent cytotoxicity exerted by 3i through apoptosis-mediated activity, this compound emerges as a promising target-oriented anticancer agent.
Reference55 articles.
1. Small hybrid heteroaromatics: Resourceful biological tools in cancer research;Abbot;RSC Adv.,2017
2. Microwave assisted synthesis, docking and antimalarial evaluation of hybrid PABA‐substituted 1, 3, 5‐triazine derivatives;Adhikari;J. Heterocycl. Chem.,2020
3. 5-(1H-Indol-3-yl)-pyrazolyl derivatives as colorimetric sensor for anions;Ahmad;J. Incl. Phenom. Macrocycl. Chem.,2012
4. Design, synthesis, biological evaluation, and molecular docking study on triazine based derivatives as anti-inflammatory agents;Asadi;J. Mol. Struct.,2021
5. 5-(4, 6-dimorpholino-1, 3, 5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/mTOR inhibitor as clinical candidate in oncology;Beaufils;J. Med. Chem.,2017
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献